About Omnicare (NYSE:OCR)
Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.
Industry, Sector and Symbol
Sub-IndustryHealth Care Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity5.37%
Return on Assets2.20%
Omnicare (NYSE:OCR) Frequently Asked Questions
What is Omnicare's stock symbol?
Omnicare trades on the New York Stock Exchange (NYSE) under the ticker symbol "OCR."
How were Omnicare's earnings last quarter?
Omnicare, Inc. (NYSE:OCR) issued its quarterly earnings results on Wednesday, February, 19th. The healthcare company reported $0.87 EPS for the quarter, missing the consensus estimate of $0.90 by $0.03. The healthcare company earned $1.54 billion during the quarter, compared to the consensus estimate of $1.59 billion. Omnicare had a return on equity of 5.37% and a net margin of 1.96%. View Omnicare's Earnings History.
Has Omnicare been receiving favorable news coverage?
Media stories about OCR stock have been trending positive on Friday, according to Accern Sentiment. The research firm rates the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Omnicare earned a news impact score of 0.42 on Accern's scale. They also assigned media stories about the healthcare company an impact score of 45.30 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of Omnicare?
Shares of OCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Omnicare's stock price today?
One share of OCR stock can currently be purchased for approximately $97.90.
How big of a company is Omnicare?
Omnicare has a market capitalization of $9.48 billion.
How can I contact Omnicare?
Omnicare's mailing address is 900 Omnicare Center 201 E. Fourth Street, CINCINNATI, OH 45202-4248, United States. The healthcare company can be reached via phone at +1-513-7192600.
MarketBeat Community Rating for Omnicare (OCR)MarketBeat's community ratings are surveys of what our community members think about Omnicare and other stocks. Vote "Outperform" if you believe OCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Omnicare (NYSE:OCR) Dividend Information
Omnicare pays an annual dividend of $0.00 per share, with a dividend yield of 0.00%. OCR's most recent quarterly dividend payment was Tuesday, June 30.
|Most Recent Dividend:||6/30/2015|
|Dividend Growth:||0.00% (3 Year Average)|
Omnicare (NYSE:OCR) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Omnicare (NYSE:OCR) SEC Filings
This page is loading this company's SEC Filings. Please wait...